The company will begin sales of its new product formats in December. It submitted 15 SKUs to Health Canada, including edibles, vape pens, and cartridges that it wants to launch this year. In addition, the company plans to submit an expanded set of SKUs in the coming months.
“The addition of cannabis derivatives to our product line enables TerrAscend to better meet the needs of patients and customers, who demand safe, standardized products,” TerrAscend CEO Michael Nashat stated.
He believes that the approval opens the door for the company to bring its U.S. brands and formulations to the Canadian market.